Runeasi plans to accelerate international expansion, with a focus on the US market, while continuing to support its established customer base in Belgium.
Runeasi, a KU Leuven spin-off focused on running and movement analysis, has raised €1 million in a new investment round. The round was led by Smarter Ventures, with participation from existing investors Freshmen Fund, Gemma Frisius Fund, the company’s founders, and angel investor Sean Gourley.
Runeasi enables physiotherapists, coaches, and speciality running stores to carry out running and jumping analyses quickly, without the need for complex or costly equipment. The platform uses an AI-powered motion sensor worn in a sports belt to capture biomechanical data, which is translated into personalised reports with actionable insights for rehabilitation, training, and exercise planning.
The company focuses on translating scientific research into practical tools that support health and human performance, allowing practitioners to convert biomechanical data into tailored training programmes.
Runeasi is currently used in more than 40 countries by sports physiotherapy practices and running specialists. To date, the platform has supported over 50,000 running analyses, with the United States representing its largest market. The company also works with sports footwear brands, enabling efficient and objective product testing and supporting scientific validation.
Commenting on the funding, CEO Kurt Schütte said the investment will support the company’s next phase of growth, with a focus on accelerating international expansion, particularly in the United States, while continuing to serve the Belgian market where Runeasi has established long-term customer relationships.
At the end of 2025, Runeasi was named among Belgium’s fastest-growing AI scale-ups. According to Schütte and co-founder and CTO Tim Op De Béeck, the recognition reinforces the company’s commitment to scientific integrity and validation, with a focus on using AI as a practical tool rather than a marketing feature.